Digital Rectal Exam Has Low Diagnostic Value for Prostate Cancer
Low diagnostic value seen as independent test and supplementary measure to PSA for detection of prostate cancer
Oral Switch Noninferior for Low-Risk S. Aureus Bloodstream Infection
Early oral antimicrobial therapy noninferior to intravenous standard therapy for low-risk bloodstream infection
Invasive Breast Cancer, Breast Cancer Mortality Increased Long Term After DCIS
Highest cumulative risks for invasive breast cancer and breast cancer death seen for women aged younger than 45 years at diagnosis
American Lung Association Blasts Biden for Inaction on Menthol Cigarette Ban
Amid Continuing Shortage, Red Cross Repeats Call for Blood Donors
The United States has the lowest number of people giving blood observed over the past 20 years
FDA: CAR T-Cell Therapies May Increase Risk for Rare Secondary Cancers
Twenty-five reports of rare blood cancers in patients who had received CAR T-cell therapy prompted agency's warning
Dana Farber Cancer Center to Retract or Fix Dozens of Studies
Soy, Enterolactone, Green Tea May Reduce Adverse Breast Cancer Outcomes
Reduced risk for recurrence seen in association with soy isoflavones; prediagnostic green tea also linked to reduced risk for recurrence
Older Adults Average 20.7 Total Health Care Contact Days a Year
Factors linked to more ambulatory contact days include younger age, female sex, White race, non-Hispanic ethnicity
Gene Therapy for Sickle Cell Disease Likely Cost-Effective at <$2 Million
Incremental cost-effectiveness ratios were $126,000 and $281,000 per QALY for two simulation models from a societal perspective
